Related Experiment Video

Updated: Jan 4, 2026

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.6K

NSCLC Evolution Studies Refine Biomarkers

    Cancer Discovery
    |November 7, 2019
    PubMed

    Abstract:

    The latest analyses from TRACERx, a major effort to understand the genetic landscape of non-small cell lung cancer, are helping researchers uncover new, potentially prognostic biomarkers and pinpoint T-cell receptors that may be useful in the development of adoptive cellular immunotherapies.

    More Related Videos

    Predictive Immune Modeling of Solid Tumors
    08:50

    Predictive Immune Modeling of Solid Tumors

    Published on: February 25, 2020

    7.4K
    Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
    10:29

    Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

    Published on: August 14, 2019

    11.0K

    Related Experiment Videos

    Last Updated: Jan 4, 2026

    Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
    07:59

    Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

    Published on: September 8, 2023

    1.6K
    Predictive Immune Modeling of Solid Tumors
    08:50

    Predictive Immune Modeling of Solid Tumors

    Published on: February 25, 2020

    7.4K
    Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
    10:29

    Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

    Published on: August 14, 2019

    11.0K

    Related Concept Videos

    Cancer Survival Analysis01:21

    Cancer Survival Analysis

    617
    Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
    617

    Articles linked to this work by shared authors, journal, and citation graph.

    Genomic alterations and treatment define spatiotemporal patterns of glioblastoma recurrence.

    Cancer discovery·2026

    Activity over Abundance: ADAMTSL4 Unlocks Latent TGFβ1 in Cancer Cachexia.

    Cancer discovery·2026

    When Neutrophils Do Not Die: Senescence as a New Axis of Tumor Immunosuppression.

    Cancer discovery·2026

    Immunologic Consequences of Genomic Instabilities.

    Cancer discovery·2026

    Quality over Quantity: Dietary Fatty Acid Composition Shapes Pancreatic Tumorigenesis.

    Cancer discovery·2026

    Studying Ferroptosis in the Tumor Microenvironment.

    Cancer discovery·2026

    MAGEA6 Promoted Gastric Cancer Progression by Activating Mitophagy.

    Molecular carcinogenesis·2026

    NET-Associated Inflammatory Markers in Head and Neck Squamous Cell Carcinoma: Bioinformatic Prioritization and Exploratory Serum Assessment in Patients Undergoing Radiotherapy.

    Molecular carcinogenesis·2026

    Impact of PD-1 and PD-L1 inhibitors on patient-reported outcomes in esophageal squamous cell carcinoma: a systematic review of clinical trials.

    Current medical research and opinion·2026

    Perfusion beyond Margin in Hepatocellular Carcinoma: A Contrast-enhanced US Feature Related to Tumor Invasiveness and Prognosis.

    Radiology·2026

    Prognostic Value of Primary Tumor and Immune Organ Metabolic Parameters Derived from Pretreatment 18F-FDG PET/CT in Gastric Adenocarcinoma: A Retrospective Survival Analysis.

    Molecular imaging and radionuclide therapy·2026

    Cell-based polygenic risk scores predict clinical progression and prioritize network-based therapeutic targets in Alzheimer's disease.

    Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us